Russell Investments Group
AMPE

Russell Investments Group’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Russell Investments Group’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,446
Closed -$220K – 3070
2018
Q3 		$220K Buy
+1,446
New +$604K ﹤0.01% 2624

Other funds holding AMPE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
MA
Montag & Associates Atlanta, Georgia $2.15B AUM 20.86% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

Russell Investments Group's AMPE Position: Q4 2018 in Review

Russell Investments Group sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2018, closing a stake of 1,446 shares — an estimated $220K sold.

Russell Investments Group first reported a position in AMPE in Q3 2018 and held it in 1 quarter. The position peaked at $220K in Q3 2018. 89 funds tracked by Wall St. Rank hold AMPE as of Q4 2018.

  • Russell Investments Group reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2018 after selling out during the quarter.
  • Russell Investments Group sold 1,446 Ampio Pharmaceuticals Inc. shares in Q4 2018, an estimated $220K.
  • Russell Investments Group first reported a position in Ampio Pharmaceuticals Inc. in Q3 2018 and held it in 1 quarter.
  • Russell Investments Group's Ampio Pharmaceuticals Inc. position peaked at $220K in Q3 2018.
  • 89 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2018.

Based on Russell Investments Group's 13F filing for Q4 2018, filed 11 Feb 2019.